LabCorp Shares Plummet as Projections Don’t Meet Reality

Brian Feroldi of Motley Fool reports that shares of the global LapCorp and CRO nosedive after management dials back full-year guidance. Management blamed the downward revision on "slower growth in referred direct-to-consumer genetic testing, lower referral volume from...

Pin It on Pinterest